Request for Covid-19 Impact Assessment of this Report
Production, means the output of Apixaban
Revenue, means the sales value of Apixaban
This report studies Apixaban in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Pfizer, Inc. (US)
Bayer Healthcare AG (Germany)
GlaxoSmithKline Plc. (UK)
Boehringer Ingelheim (Germany)
Sanofi S.A. (France)
Abbott India Limited (India)
Aspen Holdings (South Africa)
Bristol-Myers Squibb Company (US)
Eisai Inc. (US)
Mitsubishi Tanabe Pharma Corporation (Japan)
Teva Pharmaceutical Industries Ltd. (Israel)
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Apixaban in these regions, from 2011 to 2021 (forecast) , like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Apixaban in each application, can be divided into
Application 1
Application 2
Application 3
Global Apixaban Market Research Report 2016
1 Apixaban Market Overview
1.1 Product Overview and Scope of Apixaban
1.2 Apixaban Segment by Type
1.2.1 Global Production Market Share of Apixaban by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Apixaban Segment by Application
1.3.1 Apixaban Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Apixaban Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Apixaban (2011-2021)
2 Global Apixaban Market Competition by Manufacturers
2.1 Global Apixaban Production and Share by Manufacturers (2015 and 2016)
2.2 Global Apixaban Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Apixaban Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Apixaban Manufacturing Base Distribution, Sales Area and Product Type
2.5 Apixaban Market Competitive Situation and Trends
2.5.1 Apixaban Market Concentration Rate
2.5.2 Apixaban Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Apixaban Production, Revenue (Value) by Region (2011-2016)
3.1 Global Apixaban Production and Market Share by Region (2011-2016)
3.2 Global Apixaban Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Apixaban Supply (Production) , Consumption, Export, Import by Regions (2011-2016)
4.1 Global Apixaban Consumption by Regions (2011-2016)
4.2 North America Apixaban Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Apixaban Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Apixaban Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Apixaban Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Apixaban Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Apixaban Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Apixaban Production, Revenue (Value) , Price Trend by Type
5.1 Global Apixaban Production and Market Share by Type (2011-2016)
5.2 Global Apixaban Revenue and Market Share by Type (2011-2016)
5.3 Global Apixaban Price by Type (2011-2016)
5.4 Global Apixaban Production Growth by Type (2011-2016)
6 Global Apixaban Market Analysis by Application
6.1 Global Apixaban Consumption and Market Share by Application (2011-2016)
6.2 Global Apixaban Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Apixaban Manufacturers Profiles/Analysis
7.1 Pfizer, Inc. (US)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Apixaban Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Pfizer, Inc. (US) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Bayer Healthcare AG (Germany)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Apixaban Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Bayer Healthcare AG (Germany) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline Plc. (UK)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Apixaban Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 GlaxoSmithKline Plc. (UK) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Boehringer Ingelheim (Germany)
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Apixaban Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Boehringer Ingelheim (Germany) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Sanofi S.A. (France)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Apixaban Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Sanofi S.A. (France) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Abbott India Limited (India)
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Apixaban Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Abbott India Limited (India) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Aspen Holdings (South Africa)
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Apixaban Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Aspen Holdings (South Africa) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Bristol-Myers Squibb Company (US)
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Apixaban Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Bristol-Myers Squibb Company (US) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Eisai Inc. (US)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Apixaban Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Eisai Inc. (US) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Mitsubishi Tanabe Pharma Corporation (Japan)
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Apixaban Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Teva Pharmaceutical Industries Ltd. (Israel)
8 Apixaban Manufacturing Cost Analysis
8.1 Apixaban Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Apixaban
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Apixaban Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Apixaban Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Apixaban Market Forecast (2016-2021)
12.1 Global Apixaban Production, Revenue Forecast (2016-2021)
12.2 Global Apixaban Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Apixaban Production Forecast by Type (2016-2021)
12.4 Global Apixaban Consumption Forecast by Application (2016-2021)
12.5 Apixaban Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Apixaban
Figure Global Production Market Share of Apixaban by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Apixaban Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Apixaban Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Apixaban Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Apixaban Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Apixaban Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Apixaban Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Apixaban Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Apixaban Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Apixaban Production of Key Manufacturers (2015 and 2016)
Table Global Apixaban Production Share by Manufacturers (2015 and 2016)
Figure 2015 Apixaban Production Share by Manufacturers
Figure 2016 Apixaban Production Share by Manufacturers
Table Global Apixaban Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Apixaban Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Apixaban Revenue Share by Manufacturers
Table 2016 Global Apixaban Revenue Share by Manufacturers
Table Global Market Apixaban Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Apixaban Average Price of Key Manufacturers in 2015
Table Manufacturers Apixaban Manufacturing Base Distribution and Sales Area
Table Manufacturers Apixaban Product Type
Figure Apixaban Market Share of Top 3 Manufacturers
Figure Apixaban Market Share of Top 5 Manufacturers
Table Global Apixaban Production by Regions (2011-2016)
Figure Global Apixaban Production and Market Share by Regions (2011-2016)
Figure Global Apixaban Production Market Share by Regions (2011-2016)
Figure 2015 Global Apixaban Production Market Share by Regions
Table Global Apixaban Revenue by Regions (2011-2016)
Table Global Apixaban Revenue Market Share by Regions (2011-2016)
Table 2015 Global Apixaban Revenue Market Share by Regions
Table Global Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Table China Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Table India Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Apixaban Consumption Market by Regions (2011-2016)
Table Global Apixaban Consumption Market Share by Regions (2011-2016)
Figure Global Apixaban Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Apixaban Consumption Market Share by Regions
Table North America Apixaban Production, Consumption, Import & Export (2011-2016)
Table Europe Apixaban Production, Consumption, Import & Export (2011-2016)
Table China Apixaban Production, Consumption, Import & Export (2011-2016)
Table Japan Apixaban Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Apixaban Production, Consumption, Import & Export (2011-2016)
Table India Apixaban Production, Consumption, Import & Export (2011-2016)
Table Global Apixaban Production by Type (2011-2016)
Table Global Apixaban Production Share by Type (2011-2016)
Figure Production Market Share of Apixaban by Type (2011-2016)
Figure 2015 Production Market Share of Apixaban by Type
Table Global Apixaban Revenue by Type (2011-2016)
Table Global Apixaban Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Apixaban by Type (2011-2016)
Figure 2015 Revenue Market Share of Apixaban by Type
Table Global Apixaban Price by Type (2011-2016)
Figure Global Apixaban Production Growth by Type (2011-2016)
Table Global Apixaban Consumption by Application (2011-2016)
Table Global Apixaban Consumption Market Share by Application (2011-2016)
Figure Global Apixaban Consumption Market Share by Application in 2015
Table Global Apixaban Consumption Growth Rate by Application (2011-2016)
Figure Global Apixaban Consumption Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer, Inc. (US) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Apixaban Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Healthcare AG (Germany) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Healthcare AG (Germany) Apixaban Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc. (UK) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc. (UK) Apixaban Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim (Germany) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim (Germany) Apixaban Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi S.A. (France) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi S.A. (France) Apixaban Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott India Limited (India) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott India Limited (India) Apixaban Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aspen Holdings (South Africa) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Aspen Holdings (South Africa) Apixaban Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Company (US) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Company (US) Apixaban Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Inc. (US) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eisai Inc. (US) Apixaban Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Production, Revenue, Price and Gross Margin (2011-2016)
Figure Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Apixaban
Figure Manufacturing Process Analysis of Apixaban
Figure Apixaban Industrial Chain Analysis
Table Raw Materials Sources of Apixaban Major Manufacturers in 2015
Table Major Buyers of Apixaban
Table Distributors/Traders List
Figure Global Apixaban Production and Growth Rate Forecast (2016-2021)
Figure Global Apixaban Revenue and Growth Rate Forecast (2016-2021)
Table Global Apixaban Production Forecast by Regions (2016-2021)
Table Global Apixaban Consumption Forecast by Regions (2016-2021)
Table Global Apixaban Production Forecast by Type (2016-2021)
Table Global Apixaban Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...